Search

Your search keyword '"Pollock, Raphael E."' showing total 1,268 results

Search Constraints

Start Over You searched for: Author "Pollock, Raphael E." Remove constraint Author: "Pollock, Raphael E."
1,268 results on '"Pollock, Raphael E."'

Search Results

3. Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma

9. Oncogenic Functions of Alternatively Spliced MDM2-ALT2 Isoform in Retroperitoneal Liposarcoma.

10. Targeted transcriptomic analysis of well-differentiated and dedifferentiated liposarcoma reveals multiple dysregulated pathways including glucose metabolism, TGF-β, and HIF-1 signaling.

11. Adipose Tumor Microenvironment

16. Progress in sarcomas: Highlights from the 2023 annual meeting of the Connective Tissue Oncology Society

17. Mentorship Styles

18. Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue Sarcomas

20. Blockade of Interleukin-6 (IL-6) Signaling in Dedifferentiated Liposarcoma (DDLPS) Decreases Mouse Double Minute 2 (MDM2) Oncogenicity via Alternative Splicing

21. ISG15 mediates the function of extracellular vesicles in promoting ovarian cancer progression and metastasis

22. Multidisciplinary sarcoma care

23. Perioperative chemotherapy is not associated with improved survival in high-grade truncal sarcoma

25. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas

27. Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis

28. Abstract LB156: Identified the ISG15 mediated extracellular vesicles drives ovarian cancer progression and metastasis: extracellular vesicular ISG15 is a potential biomarker and therapeutic target

33. Data from Targeting the PI3K/mTOR Axis, Alone and in Combination with Autophagy Blockade, for the Treatment of Malignant Peripheral Nerve Sheath Tumors

37. Supplementary Materials and Methods from Targeting the PI3K/mTOR Axis, Alone and in Combination with Autophagy Blockade, for the Treatment of Malignant Peripheral Nerve Sheath Tumors

38. Supplementary Data from SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated Liposarcoma

39. Supplemental Document from Multimodality Treatment of Desmoplastic Small Round Cell Tumor: Chemotherapy and Complete Cytoreductive Surgery Improve Patient Survival

40. Data from Exosome-Derived miR-25-3p and miR-92a-3p Stimulate Liposarcoma Progression

41. Supplementary Figures 1 - 3 from Dual Targeting of mTOR and Aurora-A Kinase for the Treatment of Uterine Leiomyosarcoma

42. Supplemental Figure S4 from Multimodality Treatment of Desmoplastic Small Round Cell Tumor: Chemotherapy and Complete Cytoreductive Surgery Improve Patient Survival

43. Supplemental Table from MDM2 Derived from Dedifferentiated Liposarcoma Extracellular Vesicles Induces MMP2 Production from Preadipocytes

44. Supplementary Information from Exosome-Derived miR-25-3p and miR-92a-3p Stimulate Liposarcoma Progression

45. Data from MDM2 Derived from Dedifferentiated Liposarcoma Extracellular Vesicles Induces MMP2 Production from Preadipocytes

46. Supplementary Figures from MDM2 Derived from Dedifferentiated Liposarcoma Extracellular Vesicles Induces MMP2 Production from Preadipocytes

47. Supplementary Figures 1-2 from Survivin Is a Viable Target for the Treatment of Malignant Peripheral Nerve Sheath Tumors

48. Supplementary Tables 1 - 4 from Dual Targeting of mTOR and Aurora-A Kinase for the Treatment of Uterine Leiomyosarcoma

49. Supplementary Methods from Dual Targeting of mTOR and Aurora-A Kinase for the Treatment of Uterine Leiomyosarcoma

50. Supplemental Table 1 from Multimodality Treatment of Desmoplastic Small Round Cell Tumor: Chemotherapy and Complete Cytoreductive Surgery Improve Patient Survival

Catalog

Books, media, physical & digital resources